Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of InMed Pharmaceuticals (NASDAQ:INM) through any online brokerage.
Other companies in InMed Pharmaceuticals’s space includes: 60 Degrees (NASDAQ:SXTP), Addex Therapeutics (NASDAQ:ADXN), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
There is no analysis for InMed Pharmaceuticals to provide a consensus price target.
The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $1.7 last updated November 14, 2025 at 7:34 PM EST.
There are no upcoming dividends for InMed Pharmaceuticals.
InMed Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, February 11, 2026.
There is no upcoming split for InMed Pharmaceuticals.
InMed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.